Sapient

📍 San Diego, United States🗓 Founded 2020👥 43 employees💰 Last funded Dec 2021
Biotechnology Research🌐 sapient.bio
Website LinkedIn
Sapient is a biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis, enabling biopharma sponsors to go beyond the genome to accelerate precision drug development. Using state-of-the-art, high-throughput mass spectrometry technologies, Sapient enables nontargeted multi-omics measurements to capture thousands of dynamic biomarkers – including metabolites, lipids, and proteins – across thousands of samples at a time. These technologies are leveraged within a larger discovery infrastructure that includes a comprehensive biocomputational framework for analysis of large-scale, multi-omics data; robust quality control analysis; and mapping of key biomarker-phenotype associations. Sapient can cross-validate discoveries using our proprietary in-house longitudinal Human Biology Database that includes data from over 100,000 human biosamples with paired phenotypic measures. Together our approaches enable rapid identification, validation, and translation of dynamic biomarkers of biological processes, disease mechanisms, and drug response across all drug development phases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sapient?
Sapient has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Sapient last raise funding?
The most recent investment in Sapient recorded on gritt.io was in December 2021.
When was Sapient founded?
Sapient was founded in 2020.
What industry is Sapient in?
Sapient operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sapient based?
Sapient is headquartered in San Diego, United States.